GlassScriptPrepare for your visit
Zack Ramilevich
Neurology (Psychiatry & Neurology) · Boca Raton, FL · NPI 1568099851
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$11,990.95
in general payments reported to CMS, 2019-2025 · $7,788 in 2025
The $7,788 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,077.94
- Argenx US, INC. $910.11
- Ucb, INC. $868.83
- Takeda Pharmaceuticals U.S.A., INC. $736.27
- Alexion Pharmaceuticals, INC. $715.91
- Eisai INC. $629.92
Drugs and devices associated with these payments
Vyvgart Hytrulo Leqembi Hyqvia Botox Ultomiris Vyepti Nurtec Odt Crexont Kisunla Qulipta Ingrezza Purified Cortrophin Gel
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Zack Ramilevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11432152/zack-ramilevich